Development of heart valve lesions during methysergide therapy.
作者信息
Misch K A
出版信息
Br Med J. 1974 May 18;2(5915):365-6. doi: 10.1136/bmj.2.5915.365.
Abstract
摘要
相似文献
1
Development of heart valve lesions during methysergide therapy.麦角新碱治疗期间心脏瓣膜病变的发展
Br Med J. 1974 May 18;2(5915):365-6. doi: 10.1136/bmj.2.5915.365.
2
Effect of migraine treatment on heart.偏头痛治疗对心脏的影响。
Eur J Echocardiogr. 2011 Nov;12(11):880. doi: 10.1093/ejechocard/jer132. Epub 2011 Aug 17.
3
Valve disease associated with ergot alkaloid use: echocardiographic and pathologic correlations.与麦角生物碱使用相关的瓣膜疾病：超声心动图与病理学相关性
Ann Intern Med. 1992 Jul 1;117(1):50-2. doi: 10.7326/0003-4819-117-1-50.
4
From headache to heartache: ergotamine-induced aortic and mitral valvulopathy.从头痛到心痛：麦角胺诱发的主动脉瓣和二尖瓣病变。
J Am Coll Cardiol. 2013 Dec 3;62(22):2144. doi: 10.1016/j.jacc.2013.06.065. Epub 2013 Sep 22.
5
Drugs for migraine.
Med Lett Drugs Ther. 1976 Jun 18;18(13):55-6.
6
Methysergide-induced valvular heart disease: a report of 2 cases.麦角新碱诱发的心脏瓣膜病：2例报告。
Heart Surg Forum. 2006;9(5):E792-3. doi: 10.1532/hsf98.20061047.
7
Methysergide-induced heart disease: a case of multivalvular and myocardial fibrosis.麦角新碱诱发的心脏病：一例多瓣膜及心肌纤维化病例
Circulation. 1977 Nov;56(5):889-90. doi: 10.1161/01.cir.56.5.889.
8
Methysergide induced mitral valvular insufficiency.麦角新碱诱发二尖瓣关闭不全。
Conn Med. 1980 Jan;44(1):6-8.
9
Cardiac murmurs and endocardial fibrosis associated with methysergide therapy.与麦角新碱治疗相关的心脏杂音和心内膜纤维化。
Am Heart J. 1974 Nov;88(5):640-55. doi: 10.1016/0002-8703(74)90251-8.
10
[Limb ischemia and mitral valve defect as complication of migraine medication].[肢体缺血和二尖瓣缺损作为偏头痛药物治疗的并发症]
Duodecim. 1992;108(6):558-61.
引用本文的文献
1
Drug-Induced- or Rheumatic- Valvular Heart Disease in Patients Exposed to Benfluorex?服用苯氟雷司的患者是否会出现药物性或风湿性心脏瓣膜病？
PLoS One. 2016 Aug 3;11(8):e0160011. doi: 10.1371/journal.pone.0160011. eCollection 2016.
2
Risk of cardiac valvulopathy with use of bisphosphonates: a population-based, multi-country case-control study.使用双膦酸盐类药物导致心脏瓣膜病的风险：一项基于人群的多国病例对照研究。
Osteoporos Int. 2016 May;27(5):1857-67. doi: 10.1007/s00198-015-3441-2. Epub 2015 Dec 22.
3
Regulation of heart valve morphogenesis by Eph receptor ligand, ephrin-A1.Eph 受体配体 Ephrin-A1 对心脏瓣膜形态发生的调节。
Dev Dyn. 2010 Dec;239(12):3226-34. doi: 10.1002/dvdy.22458. Epub 2010 Oct 19.
4
Role of serotoninergic pathways in drug-induced valvular heart disease and diagnostic features by echocardiography.血清素能通路在药物性瓣膜性心脏病中的作用及超声心动图诊断特征
J Am Soc Echocardiogr. 2009 Aug;22(8):883-9. doi: 10.1016/j.echo.2009.05.002. Epub 2009 Jun 23.
本文引用的文献
1
METHYSERGIDE FOR PREVENTION OF HEADACHE; EXPERIENCE IN FIVE HUNDRED PATIENTS OVER THREE YEARS.麦角乙脲预防头痛；三年来五百例患者的经验
N Engl J Med. 1964 Jan 9;270:67-72. doi: 10.1056/NEJM196401092700202.
2
Cardiac and pulmonary fibrosis during methysergide therapy for headache.麦角新碱治疗头痛期间的心脏和肺部纤维化
Am J Med Sci. 1967 Jul;254(1):1-12. doi: 10.1097/00000441-196707000-00001.
3
Fibrotic syndromes with chronic use of methysergide.长期使用麦角新碱所致的纤维化综合征。
Headache. 1971 Apr;11(1):1-5. doi: 10.1111/j.1526-4610.1971.hed1101001.x.
Zotero 插件